{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:35:44Z","timestamp":1790994944358,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003751","name":"Ministerio de Sanidad, Servicios Sociales e Igualdad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.lfs.2020.118271","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T02:21:23Z","timestamp":1597285283000},"page":"118271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Behavioural and molecular effects of cannabidiolic acid in mice"],"prefix":"10.1016","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8558-8469","authenticated-orcid":false,"given":"Laia","family":"Alegre-Zurano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-8886","authenticated-orcid":false,"given":"Ana","family":"Mart\u00edn-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2264-7852","authenticated-orcid":false,"given":"Olga","family":"Valverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118271_bb0005","series-title":"Constituents of Cannabis sativa L. XVII. A Review of the Natural Constituents","author":"Turner","year":"1980"},{"key":"10.1016\/j.lfs.2020.118271_bb0010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpba.2017.05.049","article-title":"Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp)","volume":"143","author":"Brighenti","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.lfs.2020.118271_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2020.118271_bb0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2131\/jts.39.711","article-title":"Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells","volume":"39","author":"Takeda","year":"2014","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.lfs.2020.118271_bb0025","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.108.020909","article-title":"Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis","volume":"36","author":"Takeda","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2020.118271_bb0030","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1248\/bpb.34.774","article-title":"Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa","volume":"34","author":"Ruhaak","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2020.118271_bb0035","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/bph.12043","article-title":"Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation","volume":"168","author":"Bolognini","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118271_bb0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bph.12162","article-title":"Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats","volume":"169","author":"Rock","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118271_bb0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bph.14073","article-title":"Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT 1A receptor-mediated suppression of nausea and anxiety in rats","volume":"175","author":"Pertwee","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118271_bb0050","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/jpet.107.134809","article-title":"Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8","volume":"325","author":"De Petrocellis","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2020.118271_bb0055","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118271_bb0060","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbagen.2019.01.002","article-title":"Identification and characterization of phytocannabinoids as novel dual PPAR\u03b1\/\u03b3 agonists by a computational and in vitro experimental approach","volume":"1863","author":"D\u2019Aniello","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.lfs.2020.118271_bb0065","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/bph.14019","article-title":"Tetrahydrocannabinolic acid is a potent PPAR\u03b3 agonist with neuroprotective activity","volume":"174","author":"Nadal","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118271_bb0070","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00213-014-3498-1","article-title":"A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping","volume":"231","author":"Rock","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2020.118271_bb0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-015-4100-1","article-title":"Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea","volume":"233","author":"Brierley","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2020.118271_bb0080","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1007\/s00213-015-4080-1","article-title":"Effect of combined doses of \u03949-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague-Dawley) models of conditioned gaping","volume":"232","author":"Rock","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2020.118271_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-017-4626-5","article-title":"Effect of prior foot shock stress and \u03949-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","volume":"234","author":"Rock","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2020.118271_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2018.05.027","article-title":"Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression","volume":"351","author":"Hen-Shoval","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2020.118271_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-018-5034-1","article-title":"Effect of cannabidiolic acid and \u22069-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain","volume":"235","author":"Rock","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2020.118271_bb0100","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/acs.jnatprod.9b00600","article-title":"Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of Dravet syndrome","volume":"82","author":"Anderson","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2020.118271_bb0105","first-page":"579","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118271_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fpsyt.2019.00063","article-title":"The endocannabinoid system and cannabidiol\u2019s promise for the treatment of substance use disorder","volume":"10","author":"Chye","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.lfs.2020.118271_bb0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.euroneuro.2018.02.003","article-title":"Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex","volume":"28","author":"Portero-Tresserra","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2020.118271_bb0120","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","article-title":"Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attenuates morphine withdrawal","volume":"17","author":"Simonin","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2020.118271_bb0125","author":"Arai"},{"key":"10.1016\/j.lfs.2020.118271_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","article-title":"Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus","volume":"143","author":"Luj\u00e1n","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2020.118271_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/35036228","article-title":"The prefontral cortex and cognitive control","volume":"1","author":"Miller","year":"2000","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T06:21:19Z","timestamp":1717222879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520310237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"alternative-id":["S0024320520310237"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118271","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.22.165076","asserted-by":"object"}]},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioural and molecular effects of cannabidiolic acid in mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118271"}}